PRICE T ROWE ASSOCIATES INC /MD/ - LONGBOARD PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 53 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of LONGBOARD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$67,807
+41.5%
2,508,536
+13.1%
0.01%
+33.3%
Q1 2024$47,910
+388.3%
2,217,995
+36.3%
0.01%
+500.0%
Q4 2023$9,812
-0.4%
1,626,982
-8.2%
0.00%0.0%
Q3 2023$9,855
-20.6%
1,772,348
+4.8%
0.00%
-50.0%
Q2 2023$12,416
+115.7%
1,691,330
+15.5%
0.00%
+100.0%
Q1 2023$5,757
+20.6%
1,464,774
-3.1%
0.00%0.0%
Q4 2022$4,775
-99.9%
1,510,961
+0.1%
0.00%0.0%
Q3 2022$5,617,000
+20.3%
1,509,775
-0.1%
0.00%0.0%
Q2 2022$4,671,000
-40.5%
1,511,739
-0.0%
0.00%0.0%
Q1 2022$7,849,000
-19.9%
1,512,239
-25.3%
0.00%0.0%
Q4 2021$9,799,000
-51.9%
2,024,616
-11.4%
0.00%
-50.0%
Q3 2021$20,362,000
+1.3%
2,285,290
-0.1%
0.00%0.0%
Q2 2021$20,105,000
-44.5%
2,287,289
-0.7%
0.00%
-50.0%
Q1 2021$36,230,000–2,302,749–0.00%–
 Download
Other shareholders
LONGBOARD PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 900,000$5,427,0000.74%
Cormorant Asset Management, LP 2,353,141$14,189,4400.68%
Ikarian Capital, LLC 979,462$5,906,1560.55%
Parkman Healthcare Partners LLC 429,892$2,592,2490.36%
FARALLON CAPITAL MANAGEMENT LLC 1,560,500$9,409,8150.04%
Polar Capital Holdings Plc 1,000,000$6,030,0000.04%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 123,206$742,9320.04%
BOOTHBAY FUND MANAGEMENT, LLC 231,471$1,395,7700.04%
PLATINUM INVESTMENT MANAGEMENT LTD 127,048$766,0990.03%
Point72 Asset Management, L.P. 825,000$4,974,7500.01%
View complete list of LONGBOARD PHARMACEUTICALS IN shareholders